DEVICE CATEGORY · PWD
Flow Cytometric Test System For Hematopoietic Neoplasms
Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN)
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bd Biosciences | 510(k) clearance | Oct 20, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
